Lecture 18: Pancreatic Disorders Flashcards

1
Q

pancreas is both ____ and ___ organ

A

endocrine; exocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does it do as exocrine organ?

A

produce enzymes and bicarbonate necessary for digestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some exocrine hormones?

A

trypsin, chymotrypsin, carboxypeptidase, ribonyclease, elastase, lipase, cholesterol esterase, alpha amylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does it do as endocrine organ?

A

produce hormones central for substrate metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are some endocrine hormones?

A

insulin, glucagon, somatostatin, pancreatic polypeptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

valve that controls pancreatic juices is called:

A

sphincter of Oddi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

before activation, pancreatic enzymes called :

A

zymogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

zymogens only activate when enter _____

A

small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

first zymogen to activate is:

A

trypsinogen –> trypsin (activates other things)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are things that stim pancreatic secretion?

A

CCK, secretin, gastrin, VIP, cephalic phase of eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are things that inhibit pancreatic secretion?

A

GLP1, PP, PYY, OXM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pancreatitis is characterized by:

A

hemorrhage of pancreatic tissue,
edema,
autodigestion,
fat necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

types of acute pancreatitis:

A

interstitial and hemorrhagic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

acute interstitial (80-85%) characterized by:

A

gland architecture preserved but edematous, inflamm cells prominent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

acute hemorrhagic (15-20%) characterized by:

A

marked necrosis, hemorrhage of tissue, fat necrosis, vascular inflamm and thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

signs and symptoms of acute pancreatitis?

A

ab pain, nausea/vomiting, low-moderate fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

diagnostic markers for AP

A

^ pancreatic enzymes 3x greater than high end of normal (^ amylase and lipase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

__% AP caused by gallstones, ___% by alcohol, and ___ % by hypertriglyceridemiea

A

40; 30;2-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is MNT for mild AP?

A

pain limited analgesics, IVF, start progressive low fat oral diet, small meals (6x/d), eventually normal diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is MNT for severe AP?

A

NPO for pancreatic rest, EN is preferred route (traditionally)

21
Q

for EN in severe AP, feed into where?

A

gastric (NG), if not tolerated then jejunal (NJ)

22
Q

feed NJ below the ligament of ___

A

Treitz

23
Q

when to start feeding for severe AP?

A

early EN indicated, anticipate NPO >5-7days

24
Q

rate (modality) of feed for severe AP?

A

continuous

25
Q

severe AP need ___ kcal/kg, protein ____ g/kg

A

25-35; 1.2-1.5

26
Q

EN preferred for SAP cuz:

A

v mortality, v septic complications, v surgical procedures, v hospital LOS, ^ trophic action on intestinal wall, prevent/reduce bacteria translocation

27
Q

when is PN warranted for SAP?

A

EN not tolerated or contraindicated for other reasons

28
Q

examples of irreversible morphological changes of CP?

A

fibrosis, calcifications/stones, loss of islet/acinar cells

29
Q

exocrine/endocrine insufficiency associated with:

A

steatorrhea, wt loss, malnutrition

30
Q

clinical manifestations of CP:

A

ab pain with/without exocrine/endocrine insufficiency, pain which is increased by fatty food and alcohol intake (result in anorexia)

31
Q

etiopathogenic risk factors for CP:

A

toxic metabolic (alcoholism, smoking, hypertriglyceridemia), genetic mutations, autoimmune pancreatitis, obstructive, idiopathic

32
Q

exocrine insufficiency is attributed to:

A

loss of acinar cell mass or pancreatic duct obstruction–>v digestive enzymes, v ductal bicarbonate secreted

33
Q

endocrine insufficiency is attributable to destruction of pancreatic _____ which results in loss of islet cells, or _____ diabetes

A

parenchyma; pancreatogenic (type 3c)

34
Q

nutr implications of exocrine insufficiency in CP?

A

fat maldigestion (steatorrhea), CHO and protein maldigestion (v amylase, v trypsin)

35
Q

steatorrhea occurs when pancreatic lipase secretion < ___% of normal, and is the primary cause of ____ in CP

A

10; weight loss

36
Q

steatorrhea = fecal fat excretion > __g/d

A

7

37
Q

v amylase secretion causes:

A

impaired CHO digestion, abdo distension, gas, loose stools

38
Q

vit ____ deficiencies most common

A

A and E

39
Q

clinical manifestations of deficiencies in fat sol vits?

A

vision, bone density

40
Q

average resting expenditure in CP is ___kcal/day > than average

A

200

41
Q

3 pronged approach to nutr management of CP:

A

1) pancreatic enzyme replacement therapy
2) assessment/correction of nutr deficiencies
3) maintain adequate diet intake and avoid alcohol

42
Q

enzymes in PERT usually combo of ____

A

lipase, protease, amylase

43
Q

example of PERT:

A

cotazyme (also used in EN feed tube clogged)

44
Q

if uncoated, use with ____ (eg. PPI)

A

gastric acid suppressant

45
Q

timing of PERT?

A

with/just before eating

46
Q

if on PERT, need to know these things:

A

adherence, dose, timing of doses

47
Q

nutr recommendations for CP?

A

high energy (35kcal/kg), high protein (1-1.5g/kg), fat restriction if steatorrhea persists (MCT oil?)

48
Q

v trypsin secretion means less ____ digestion

A

protein